West Pharmaceutical Services, Inc. (WST) Comparison with companies in other sectors?

West Pharmaceutical Services, Inc. has a share price of 71.85M. You can analyze West Pharmaceutical Services, Inc. (WST) competitors across different market sectors through stock heatmaps.

What are WST's NET and operating margins?

West Pharmaceutical Services, Inc. (WST) operating margin is around 0.20, and net profit margin is approximately 0.16 as of the latest reports.

In what way does WST's earnings per share (EPS) trend reflect its financial momentum?

West Pharmaceutical Services, Inc. (WST) EPS is 6.67 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for West Pharmaceutical Services, Inc. is 39.48, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for West Pharmaceutical Services, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for West Pharmaceutical Services, Inc. like P/E which is 39.39, P/B which is 0.00, and PEG which is 8.43. Compare them with sector averages to evaluate if the stock is priced fairly.

West Pharmaceutical Services, Inc.

WST•NYSE

Healthcare

Medical - Instruments & Supplies

$260.08

$-19.02(-6.81%)

West Pharmaceutical Services, Inc. (WST) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$6.67

P/E Ratio

39.48

ROE

0.24%

Net Margin

0.16%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$18.92B

Shares OutstandingTotal number of shares issued

$71.85M

Book Value/ShareNet worth per share

$6.77

Revenue/ShareAnnual revenue per share

$40.94

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$6.67

Net MarginNet income as percentage of revenue

16.48%

Operating MarginOperating income as percentage of revenue

19.65%

ROEReturn on shareholders' equity

24.03%

ROAReturn on total assets

32.23%

ROCEReturn on capital employed

64.01%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.76

Cash/ShareCash and equivalents per share

$7.05

FCF YieldFree cash flow as percentage of market cap

1.81%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.83

Dividend YieldAnnual dividend as percentage of stock price

0.31%

Financial Ratios Analysis data is not available for WSTFinancial Ratios Analysis details for WST are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for WSTSector Benchmarking details for WST are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for West Pharmaceutical Services, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of West Pharmaceutical Services, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account West Pharmaceutical Services, Inc.'s unique business strengths and challenges.

Key Financial Metrics for West Pharmaceutical Services, Inc.

For West Pharmaceutical Services, Inc., essential financial indicators include EPS 6.67, PE 39.48, and ROE 0.24. These key ratios reveal insights into West Pharmaceutical Services, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare West Pharmaceutical Services, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of West Pharmaceutical Services, Inc.

Metrics like Net Margin 16.48% and ROA 32.23% shed light on how well West Pharmaceutical Services, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether West Pharmaceutical Services, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of West Pharmaceutical Services, Inc.

Using ratios such as P/B Ratio - and PEG Ratio 8.43, investors can assess whether West Pharmaceutical Services, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with West Pharmaceutical Services, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for West Pharmaceutical Services, Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $4.76, provide a snapshot of West Pharmaceutical Services, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like West Pharmaceutical Services, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for West Pharmaceutical Services, Inc.

Investing in West Pharmaceutical Services, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at West Pharmaceutical Services, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;